Filter your search
Oncology Hematology Market ReportsX
Cancer diagnosis and treatment represents a significant expenditure in developed healthcare systems. Cancer screening is performed through routine tests such as complete blood counts (CBCs), differentials, and protein markers. However, the global oncology diagnostics market is quickly evolving past established markers and companion diagnostics in the United States, Europe and Japan. Targeted cancer therapies are finding significant demand in emerging middle-income countries such as China and new technologies such as liquid biopsies, next-generation sequencing (NGS) and novel hybridization assays are being developed for cancer detection and diagnosis. Kalorama Information market research covers cancer diagnostics from multiple angles of diagnostic technology and regional demand.
- $995.00 – $1,990.00Full coverage of the IVD market in Mexico, including important IVD segments.December 16, 2013$1,995.00 – $4,000.00The World Market for Hematology Used for both critical and routine testing, hematology is a central part of IVD. CBCs contribute to the general assessment of health for patients during regular check-ups. Conditions such as anemia, other blood disorders, infection, allergy, iron and vitamin deficiencies are easily diagnosed through a CBC. This report, authored by […]November 22, 2013$1,995.00 – $3,900.00What is the procedure, for establishing reimbursement for an IVD test product? What companies have been successful and how? What changes will IVD makers face in the near-term. This Kalorama Information report, Reimbursement for In Vitro Diagnostic Tests, answers these questions and provides authoritative data for IVD business planners. One of the critical factors for […]October 25, 2013$2,995.00 – $6,750.00The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives Cancer testing is maturing from personalized medicine to precision medicine, where protein and molecular biomarkers are essential for precise diagnosis, therapy selection, therapy monitoring and early detection of cancer recurrence. The market for cancer testing are comprehensively covered in Kalorama Information’s Worldwide […]May 8, 2013$1,995.00 – $3,990.00IVD Procedure Volume and Pricing Analysis This report examines the global procedure volumes for IVD and laboratory tests. It covers only commercialized tests, specifically excluding those that are developmental or used primarily for research purposes.. Point of Care (Glucose, Pregnancy, Other) CoreLab (General Chemistries, Blood Gas Analyzers, Urinalysis, Immunoassays Infectious Disease, Cardiac Markers, Diabetes/HbA1c, Autoimmune) […]January 31, 2013$4,500.00 – $9,000.00Molecular diagnostics is becoming a dominant platform in clinical medicine and represents one of the fastest growing segments of the IVD market. As analyst Shara Rosen, R.T., MBA. details, in recent years years the number of assays introduced has been growing at a remarkable clip. This report, The World Market for Molecular Diagnostics (Infectious Disease, Oncology, […]January 9, 2013$995.00 – $1,995.00Mobile health has reached in vitro diagnostics and as this Kalorama report details, may change the industry forever. Over the years, the introduction of transportable, portable, and handheld instruments has resulted in the migration of clinical lab testing from the central lab to a range of environments including self-testing, community clinics, the workplace, home, disaster […]August 15, 2012$2,995.00 – $7,990.00In eight best-selling editions, Shara Rosen has detailed the market for in vitro diagnostic (IVD) testing, throughout the world, in one complete volume. The report, The Worldwide Market for In Vitro Diagnostic Tests, is a testament to the Kalorama methodology. Real industry knowledge combined with an exhaustive review of the medical, business, and company literature. […]July 27, 2012$1,995.00 – $4,995.00This Kalorama Information report – The World Market for Cancer Therapeutics and Biotherapeutics (Chemotherapy Agents, Interleukins/interferons, Monoclonal Antibodies, Hormone and Other Therapies) represents the fourth time that Kalorama Information has taken a comprehensive look at oncology therapeutics. The report focuses on several segments for cancer treatment including: Chemotherapy, – Subcategories include Alkylating Agents, Antimetabolites, Cytotoxic […]January 1, 2012$1,500.00 – $2,500.00This bundle provides customers with three of the most intensely researched Kalorama Information reports covering the diagnostic industry authored by Shara Rosen, R.T., M.B.A. in 2010 and 2011 These reports will be provided in one PDF, each with its own table of contents. The bundle allows customers to save almost $4,500 off the cost of […]March 1, 2011
